Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

AZELASTINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Azelastine Hydrochloride, and when can generics launch?

Azelastine Hydrochloride is a drug marketed by Sandoz Inc, Upsher-smith Labs, Apotex Inc, Sun Pharma Global, Perrigo Israel, West-ward Pharms Int, Akorn, and Breckenridge Pharm. and is included in eleven NDAs.

The generic ingredient in AZELASTINE HYDROCHLORIDE is azelastine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride profile page.

Summary for Tradename: AZELASTINE HYDROCHLORIDE

Patents:0
Applicants:8
NDAs:11
Suppliers / Packagers: see list11
Bulk Api Vendors: see list92
Clinical Trials: see list993
Patent Applications: see list3,528
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZELASTINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: AZELASTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC202305-001May 31, 2012ATRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SPRAY, METERED;NASAL091444-001Oct 24, 2014ABRXNoNo► Subscribe► Subscribe
Sun Pharma Global
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SPRAY, METERED;NASAL090423-001May 23, 2012ABRXNoNo► Subscribe► Subscribe
Apotex Inc
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SPRAY, METERED;NASAL201846-001Aug 31, 2012ABRXNoNo► Subscribe► Subscribe
Upsher-smith Labs
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SPRAY, METERED;NASAL202609-001Mar 17, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot